Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study

10.1186/cc10307

Saved in:

Bibliographic Details
Main Authors:	Hasslacher, J, Bijuklic, K, Bertocchi, C, Kountchev, J, Bellmann, R, Dunzendorfer, S, Joannidis, M
Other Authors:	MECHANOBIOLOGY INSTITUTE
Format:	Article
Published:	2020
Subjects:	dobutamine formylmethionylleucylphenylalanine levosimendan noradrenalin phorbol 13 acetate 12 myristate reactive oxygen metabolite cardiotonic agent hydrazone derivative pyridazine derivative simendan acute heart failure adult aged apoptosis article clinical article continuous infusion controlled study drug blood level female flow cytometry heart hemodynamics human human cell in vitro study kidney function male neutrophil observational study priority journal prospective study protein expression septic shock acute disease Austria drug antagonism drug effect heart failure middle aged pathophysiology Acute Disease Aged Aged, 80 and over Cardiotonic Agents Female Flow Cytometry Heart Failure Humans Hydrazones Male Middle Aged Neutrophils Prospective Studies Pyridazines Reactive Oxygen Species Shock, Septic
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/180856
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-180856
record_format	dspace
spelling	sg-nus-scholar.10635-1808562023-08-29T09:23:44Z Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study Hasslacher, J Bijuklic, K Bertocchi, C Kountchev, J Bellmann, R Dunzendorfer, S Joannidis, M MECHANOBIOLOGY INSTITUTE dobutamine formylmethionylleucylphenylalanine levosimendan noradrenalin phorbol 13 acetate 12 myristate reactive oxygen metabolite cardiotonic agent hydrazone derivative pyridazine derivative reactive oxygen metabolite simendan acute heart failure adult aged apoptosis article clinical article continuous infusion controlled study drug blood level female flow cytometry heart hemodynamics human human cell in vitro study kidney function male neutrophil observational study priority journal prospective study protein expression septic shock acute disease Austria drug antagonism drug effect heart failure middle aged pathophysiology septic shock Acute Disease Aged Aged, 80 and over Austria Cardiotonic Agents Female Flow Cytometry Heart Failure Humans Hydrazones Male Middle Aged Neutrophils Prospective Studies Pyridazines Reactive Oxygen Species Shock, Septic 10.1186/cc10307 Critical Care 15 4 R166 2020-10-27T04:58:19Z 2020-10-27T04:58:19Z 2011 Article Hasslacher, J, Bijuklic, K, Bertocchi, C, Kountchev, J, Bellmann, R, Dunzendorfer, S, Joannidis, M (2011). Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study. Critical Care 15 (4) : R166. ScholarBank@NUS Repository. https://doi.org/10.1186/cc10307 1364-8535 https://scholarbank.nus.edu.sg/handle/10635/180856 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	dobutamine formylmethionylleucylphenylalanine levosimendan noradrenalin phorbol 13 acetate 12 myristate reactive oxygen metabolite cardiotonic agent hydrazone derivative pyridazine derivative reactive oxygen metabolite simendan acute heart failure adult aged apoptosis article clinical article continuous infusion controlled study drug blood level female flow cytometry heart hemodynamics human human cell in vitro study kidney function male neutrophil observational study priority journal prospective study protein expression septic shock acute disease Austria drug antagonism drug effect heart failure middle aged pathophysiology septic shock Acute Disease Aged Aged, 80 and over Austria Cardiotonic Agents Female Flow Cytometry Heart Failure Humans Hydrazones Male Middle Aged Neutrophils Prospective Studies Pyridazines Reactive Oxygen Species Shock, Septic
spellingShingle	dobutamine formylmethionylleucylphenylalanine levosimendan noradrenalin phorbol 13 acetate 12 myristate reactive oxygen metabolite cardiotonic agent hydrazone derivative pyridazine derivative reactive oxygen metabolite simendan acute heart failure adult aged apoptosis article clinical article continuous infusion controlled study drug blood level female flow cytometry heart hemodynamics human human cell in vitro study kidney function male neutrophil observational study priority journal prospective study protein expression septic shock acute disease Austria drug antagonism drug effect heart failure middle aged pathophysiology septic shock Acute Disease Aged Aged, 80 and over Austria Cardiotonic Agents Female Flow Cytometry Heart Failure Humans Hydrazones Male Middle Aged Neutrophils Prospective Studies Pyridazines Reactive Oxygen Species Shock, Septic Hasslacher, J Bijuklic, K Bertocchi, C Kountchev, J Bellmann, R Dunzendorfer, S Joannidis, M Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study
description	10.1186/cc10307
author2	MECHANOBIOLOGY INSTITUTE
author_facet	MECHANOBIOLOGY INSTITUTE Hasslacher, J Bijuklic, K Bertocchi, C Kountchev, J Bellmann, R Dunzendorfer, S Joannidis, M
format	Article
author	Hasslacher, J Bijuklic, K Bertocchi, C Kountchev, J Bellmann, R Dunzendorfer, S Joannidis, M
author_sort	Hasslacher, J
title	Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study
title_short	Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study
title_full	Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study
title_fullStr	Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study
title_full_unstemmed	Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study
title_sort	levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/180856
_version_	1779152727949967360

Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: A prospective observational study

Similar Items